Metropolitan Life Insurance Company (MetLife)’s Inotiv NOTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-958
Closed -$16.1K 2362
2022
Q3
$16.1K Hold
958
﹤0.01% 2124
2022
Q2
$9.2K Hold
958
﹤0.01% 2316
2022
Q1
$25.1K Sell
958
-3,103
-76% -$87.1K ﹤0.01% 1986
2021
Q4
$171K Hold
4,061
﹤0.01% 2130
2021
Q3
$119K Hold
4,061
﹤0.01% 2430
2021
Q2
$108K Buy
+4,061
New +$102K ﹤0.01% 2557

Other funds holding NOTV

Metropolitan Life Insurance Company (MetLife)'s NOTV Position: Q4 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Inotiv (NOTV) in Q4 2022, closing a stake of 958 shares — an estimated $16.1K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in NOTV in Q2 2021 and held it in 6 quarters. The position peaked at $171K in Q4 2021. 80 funds tracked by Wall St. Rank hold NOTV as of Q4 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Inotiv position as of Q4 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 958 Inotiv shares in Q4 2022, an estimated $16.1K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Inotiv in Q2 2021 and held it in 6 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Inotiv position peaked at $171K in Q4 2021.
  • 80 funds tracked by Wall St. Rank held Inotiv as of Q4 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2022, filed 15 Feb 2023.